Wonbiogen (A307280) Stock Overview
Manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
A307280 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Wonbiogen Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩7,430.00 |
| 52 Week High | ₩8,400.00 |
| 52 Week Low | ₩4,765.00 |
| Beta | 0.61 |
| 1 Month Change | 2.91% |
| 3 Month Change | -4.50% |
| 1 Year Change | n/a |
| 3 Year Change | -28.90% |
| 5 Year Change | -36.09% |
| Change since IPO | -62.66% |
Recent News & Updates
Wonbiogen Co., Ltd. (KOSDAQ:307280) Shares Fly 27% But Investors Aren't Buying For Growth
Wonbiogen Co., Ltd. ( KOSDAQ:307280 ) shares have continued their recent momentum with a 27% gain in the last month...Here's Why We Think Wonbiogen (KOSDAQ:307280) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Wonbiogen (KOSDAQ:307280) Has Affirmed Its Dividend Of ₩20.00
The board of Wonbiogen Co., Ltd. ( KOSDAQ:307280 ) has announced that it will pay a dividend on the 15th of April, with...Recent updates
Shareholder Returns
| A307280 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 11.2% | 1.5% | 4.6% |
| 1Y | n/a | -3.6% | 186.6% |
Return vs Industry: Insufficient data to determine how A307280 performed against the KR Medical Equipment industry.
Return vs Market: Insufficient data to determine how A307280 performed against the KR Market.
Price Volatility
| A307280 volatility | |
|---|---|
| A307280 Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 9.0% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in KR Market | 16.6% |
| 10% least volatile stocks in KR Market | 4.9% |
Stable Share Price: A307280 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A307280's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 77 | Kim Won | www.wonbiogen.co.kr |
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities.
Wonbiogen Co., Ltd. Fundamentals Summary
| A307280 fundamental statistics | |
|---|---|
| Market cap | ₩52.70b |
| Earnings (TTM) | ₩7.04b |
| Revenue (TTM) | ₩36.27b |
Is A307280 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A307280 income statement (TTM) | |
|---|---|
| Revenue | ₩36.27b |
| Cost of Revenue | ₩17.59b |
| Gross Profit | ₩18.68b |
| Other Expenses | ₩11.64b |
| Earnings | ₩7.04b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 992.81 |
| Gross Margin | 51.50% |
| Net Profit Margin | 19.42% |
| Debt/Equity Ratio | 4.8% |
How did A307280 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/24 20:48 |
| End of Day Share Price | 2026/05/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wonbiogen Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dong Gun Lee | Shinhan Investment Corp. |
| Dong Gun Lee | SK Securities Co., Ltd. |